Topics

"A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies" Drugs and Medication Database

12:56 EST 20th February 2020 | BioPortfolio

Here are the most relevant "A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies" Drugs and Medications that we have found in our database.

More Information about "A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies" on BioPortfolio

We have published hundreds of A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies news stories on BioPortfolio along with dozens of A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies Clinical Trials and PubMed Articles about A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies Companies in our database. You can also find out about relevant A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies Drugs and Medications on this site too.

Showing "Study HSP90 Inhibitor linked Probe Solid Malignancies" Drugs and Medications 1–25 of 37

Possibly Relevant

Droxia [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use DROXIA safely and effectively. See full prescribing information for DROXIA.DROXIA (hydroxyurea) capsules, for oral useInitial U.S. Approval: 1967

Phocal apf [u.s.i.a. inc]

phocal™

Elitek [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use ELITEK safely and effectively. See full prescribing information for ELITEK. ELITEK (rasburicase) for injection, for intravenous useInitial U.S. Approval: 2002

Xeljanz [u.s. pharmaceuticals]

These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ. XELJANZ (tofacitinib) tablets, for oral use XELJANZ XR (tofacitinib) extended-release tablets, for o

Xeljanz [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR. XELJANZ (tofacitinib) tablets, for oral use XELJANZ XR (tofacitinib) extended-release tab

Estradiol [directrx]

ESTRADIOL

Cotellic [genentech, inc.]

These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for oral useInitial U.S. Approval: 2015

Mycophenolate mofetil [cadila healthcare limited]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Mycophenolate mofetil [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Simponi aria [janssen biotech, inc.]

These highlights do not include all the information needed to use SIMPONI ARIA safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA (golimumab) injection, for intravenous use Initial U.S. Approval: 2009

Tamoxifen citrate [bryant ranch prepack]

TAMOXIFEN CITRATE TABLETS, USP

Mycophenolate mofetil [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use MYCOPHENOLATE MOFETIL CAPSULES safely and effectively. See full prescribing information for MYCOPHENOLATE MOFETIL CAPSULES. MYCOPHENOLATE MOFETIL capsules, for oral use Initial U.S. Appr

Nizatidine [dispensing solutions inc.]

Nizatidine Capsules USP Rx only

Granix [cephalon, inc.]

These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012

Orencia [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use ORENCIA safely and effectively. See full prescribing information for ORENCIA. ORENCIA (abatacept) for injection, for intravenous useORENCIA (abatacept) injection, for subcutaneous useInitia

Cosmegen [recordati rare diseases, inc.]

These highlights do not include all the information needed to use COSMEGEN safely and effectively. See full prescribing information for COSMEGEN. COSMEGEN (dactinomycin for injection) for intravenous use Initial U.S. Approval: 1964

Cyclophosphamide [physicians total care, inc.]

CYCLOPHOSPHAMIDE Tablets USP, 25 mg and 50 mg

Pamidronate disodium [fresenius kabi usa, llc]

Pamidronate Disodium Injection

Thymoglobulin [genzyme corporation]

These highlights do not include all the information needed to use THYMOGLOBULIN safely and effectively. See full prescribing information for THYMOGLOBULIN. THYMOGLOBULIN (anti-thymocyte globulin [rabbit]) for intravenous use Initial U.S. Approval: 1998

Fludeoxyglucose f 18 [centre for probe development and commercialization]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection USP, for intravenous use Initial U.S.

Lamivudine [remedyrepack inc.]

These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets for oral use Initial U.S. Approval: 1995

Empliciti [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use EMPLICITI safely and effectively. See full prescribing information for EMPLICITI. EMPLICITI (elotuzumab) for injection, for intravenous useInitial U.S. Approval: 2015

Pamidronate disodium [mylan institutional llc]

Pamidronate Disodium Injection

Peg-3350 and electrolytes [lannett company, inc..]

PEG-3350 & ELECTROLYTES FOR ORAL SOLUTIONRx Only

Pamidronate disodium [hospira, inc.]

Pamidronate Disodium Injection



Quick Search